Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid vs Observation for Bone Loss in Women Undergoing Oophorectomy
NCT00305695Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Nov 2005
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in osteoporosis comparing Zoledronic Acid with Observation (2 arms). Primary endpoints: Bone Mineral Density of the Lumbar Spine at 18 months and Bone Mineral Density of the Total Hip at 18 months. Started Nov 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00305695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305695.